Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Shares Issued (2023 - 2025)

Zenas BioPharma has reported Shares Issued over the past 3 years, most recently at -$2.2 million for Q4 2025.

  • Quarterly results put Shares Issued at -$2.2 million for Q4 2025, up 99.15% from a year ago — trailing twelve months through Dec 2025 was $276000.0 (changed 0.36% YoY), and the annual figure for FY2025 was $276000.0, changed 0.36%.
  • Shares Issued for Q4 2025 was -$2.2 million at Zenas BioPharma, down from $664000.0 in the prior quarter.
  • Over the last five years, Shares Issued for ZBIO hit a ceiling of $258.7 million in Q3 2024 and a floor of -$258.6 million in Q4 2024.
  • Median Shares Issued over the past 3 years was $99000.0 (2025), compared with a mean of $66777.8.
  • Biggest five-year swings in Shares Issued: crashed 517282.0% in 2024 and later surged 1288.71% in 2025.
  • Zenas BioPharma's Shares Issued stood at $50000.0 in 2023, then crashed by 517282.0% to -$258.6 million in 2024, then surged by 99.15% to -$2.2 million in 2025.
  • The last three reported values for Shares Issued were -$2.2 million (Q4 2025), $664000.0 (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.